Autres langues Highnoon Laboratories Limited

Actions

HINOON

PK0070701013

Produits pharmaceutiques

Cours en clôture Pakistan S.E. 21/08/2026			Varia. 5j.	Varia. 1 janv.
987,43 ^PKR	+1,04 %		-1,61 %	-3,43 %

19/05	Highnoon Laboratories nomme le Dr Shahzad Khan au poste de directeur général de Highnoon Life Sciences	CI
30/04	Highnoon Laboratories Limited approuve le dividende final en numéraire pour l'exercice clos le 31 décembre 2025	CI

Autres langues

19/05	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences
05/05	Highnoon Laboratories : Video Recording of Corporate Briefing Session Highnoon Laboratories Limited
30/04	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025
29/04	Highnoon Laboratories Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Highnoon Laboratories : Notice of Corporate Briefing Session -Highnoon Laboratories Limited
10/04	Highnoon Laboratories : Statement of Material Facts under 134 (3)
08/04	Highnoon Laboratories Limited announces Annual dividend, payable on May 15, 2026
07/04	Highnoon Laboratories Limited Reports Earnings Results for the Full Year Ended December 31, 2025
06/04	Highnoon Laboratories : Board Meeting in Progress
30/03	Highnoon Laboratories : Board Meeting
02/02	Highnoon Laboratories Limited Considers Strategic Acquisition to Bolster Market Position
02/02	Highnoon Laboratories : Material Information
02/02	Highnoon Laboratories : Appointment of Head of Internal Audit
02/02	Highnoon Laboratories Limited Appoints Rizwan Shahid as Head of Internal Audit, Effective January 27, 2026
26/01	Highnoon Laboratories : Board Meeting Other Then Financial Results
10/12	Highnoon Laboratories : Resignation of Head of Internal Audit
29/10/25	Highnoon Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
28/08/25	Highnoon Laboratories : Financial Results for the Quarter Ended 30.06.2025
28/08/25	Highnoon Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
29/07/25	Highnoon Laboratories Limited and Beximco Pharmaceuticals Limited Enter into Agreement for Distribution and Marketing of Pharmaceutical Products in Pakistan
01/07/25	Highnoon Laboratories : Change of Chairman
01/07/25	Highnoon Laboratories Limited Announces Board Changes, Effective July 01, 2025
24/06/25	Highnoon Laboratories : Board Meeting Other Then Financial Results
11/06/25	Highnoon Laboratories : Corporate Briefing Session 2024 - Presentation
11/06/25	Highnoon Laboratories : Miscellaneous Information